Longevity Ventures

General contacts
Investor type

VC

Founded

-

AUM

-

Location

New York, New York, United States

Investment Ticket

$10-50 m

Investment Stage

Seed

Region of investment

North America
Investor profile last updated: 12 July, 2026

Profile

Longevity Ventures is an investor focusing on breakthroughs in the field of longevity. Their headquarters are not explicitly listed on their site, but they are dedicated to supporting transformative companies in the longevity space. Details on their founding year, team composition, or what sets them apart are not available from the provided sources.

Longevity Ventures invests primarily in sectors related to health and longevity, including biotechnology and MedTech. The specific investment stages and geographic preferences are not mentioned on their website, but they maintain a portfolio of companies striving to extend human life through innovative solutions. Information regarding the firm's total assets under management or strategic partners is not available.

Their portfolio features companies like Senda - focused on biotechnology, Biolinq - working in health monitoring, LyGenesis - involved in organ regeneration, Laronde - specializing in therapeutic platforms, and 4DMT - innovating gene therapy solutions. Other notable companies include Tessera, Eko, Exo, Sigilon, Insilico, Freenome, and Valo, each contributing to the advancement of health and longevity technologies.

Industry

AI Pharmaceuticals Medical Devices Healthcare Services Biotechnology HealthTech MedTech

Contacts

Name
Title
Email
Social Networks
Upgrade to see contacts
avatar
wz8SpiE09lbGQgcs wz8SpiE09lbGQgcs
wz8SpiE09lbGQgcs
[email protected]
linkedin twitter
avatar
wz8SpiE09lbGQgcs wz8SpiE09lbGQgcs
wz8SpiE09lbGQgcs
[email protected]
linkedin twitter
avatar
wz8SpiE09lbGQgcs wz8SpiE09lbGQgcs
wz8SpiE09lbGQgcs
[email protected]
linkedin twitter
avatar
wz8SpiE09lbGQgcs wz8SpiE09lbGQgcs
wz8SpiE09lbGQgcs
[email protected]
linkedin twitter
avatar
wz8SpiE09lbGQgcs wz8SpiE09lbGQgcs
wz8SpiE09lbGQgcs
[email protected]
linkedin twitter
Investment-team contacts for Longevity Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Longevity Ventures

Longevity Ventures is a venture capital firm. It backs companies at Seed, writing tickets of $10-50 m.
Longevity Ventures is located in New York, New York, United States.
Longevity Ventures was founded in .
Longevity Ventures invests in companies and startups in AI, Pharmaceuticals, Medical Devices, Healthcare Services, Biotechnology, HealthTech, MedTech.
Longevity Ventures invests in companies and startups in North America.
Longevity Ventures invests in companies and startups at Seed.
Longevity Ventures usually invests $10-50 m on average.
Longevity Ventures can be reached through its website lvf.vc. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Longevity Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Longevity Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 12 July, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.